Kala Visvanathan
Impact in
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
- Oncology top 0.5%
- Cancer Risks and Factors
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 100
- Cancer Risks and Factors 32
- Global Cancer Incidence and Screening 17
- Pancreatic and Hepatic Oncology Research 15
-
- Breast Cancer Treatment Studies 19
- Co-authors
- Patricia A. Hartge (6 shared papers)Martha S. Linet (5 shared papers)Amy Berrington de González (5 shared papers)Linda A. Sharp (6 shared papers)Charles Edwards Matthews (4 shared papers)Elisabete Weiderpass (3 shared papers)Steven C. Moore (4 shared papers)Alpa V. Patel (4 shared papers)
- Journals
- Cancer Epidemiology Biomarkers & Prevention (30 papers)JNCI Journal of the National Cancer Institute (19 papers)International Journal of Cancer (14 papers)Journal of Clinical Oncology (13 papers)Cancer Causes & Control (11 papers)
- Partner nations
- United StatesSwedenUnited Kingdom
In The Last Decade
Kala Visvanathan
310 papers receiving 17.2k citations
Kala Visvanathan's Hit Papers
Peers
Comparison fields: 5 of 172
- Cancer Research 2.9k
- Oncology 4.1k
- Reproductive Medicine 1.2k
- Genetics 2.9k
- Pathology and Forensic Medicine 1.6k
Countries citing papers authored by Kala Visvanathan
This map shows the geographic impact of Kala Visvanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kala Visvanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kala Visvanathan more than expected).
Fields of papers citing papers by Kala Visvanathan
This network shows the impact of papers produced by Kala Visvanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kala Visvanathan. The network helps show where Kala Visvanathan may publish in the future.
Co-authors
The 25 scholars most cited alongside Kala Visvanathan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 323 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Leisure Time Physical Activity and Mortality Hit paper breakdown → | 2015 | 1130 |
| 2 | Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2021 | 781 |
| 3 | Leisure Time Physical Activity of Moderate to Vigorous Intensity and Mortality: A Large Pooled Cohort Analysis Hit paper breakdown → | 2012 | 515 |
| 4 | 2012 | 479 | |
| 5 | Beta Blockers and Breast Cancer Mortality: A Population- Based Study Hit paper breakdown → | 2011 | 470 |
| 6 | Discovery of common and rare genetic risk variants for colorectal cancer Hit paper breakdown → | 2018 | 388 |
| 7 | Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium Hit paper breakdown → | 2016 | 388 |
| 8 | NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020 Hit paper breakdown → | 2020 | 387 |
| 9 | 2006 | 345 | |
| 10 | Association between Class III Obesity (BMI of 40–59 kg/m2) and Mortality: A Pooled Analysis of 20 Prospective Studies Hit paper breakdown → | 2014 | 326 |
| 11 | 2012 | 310 | |
| 12 | 2007 | 279 | |
| 13 | 2018 | 277 | |
| 14 | 2014 | 274 | |
| 15 | 2013 | 258 | |
| 16 | 2009 | 237 | |
| 17 | 2018 | 230 | |
| 18 | 2011 | 225 | |
| 19 | 2012 | 210 | |
| 20 | 2018 | 204 |
About Kala Visvanathan
Kala Visvanathan is a scholar working on Oncology, Cancer Research, Reproductive Medicine, Genetics and Pathology and Forensic Medicine, having authored 323 papers that have together received 17.6k indexed citations. Recurring topics across this work include Cancer Risks and Factors (32 papers), Ovarian cancer diagnosis and treatment (28 papers), BRCA gene mutations in cancer (21 papers), Breast Cancer Treatment Studies (19 papers), Global Cancer Incidence and Screening (17 papers), Estrogen and related hormone effects (16 papers), Pancreatic and Hepatic Oncology Research (15 papers) and Endometrial and Cervical Cancer Treatments (14 papers). The work is most often cited by research in Cancer Research (2.9k citations), Oncology (4.1k citations), Reproductive Medicine (1.2k citations), Genetics (2.9k citations) and Pathology and Forensic Medicine (1.6k citations). Kala Visvanathan has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Patricia A. Hartge, Martha S. Linet, Amy Berrington de González, Linda A. Sharp, Charles Edwards Matthews, Elisabete Weiderpass, Steven C. Moore, Alpa V. Patel, Thomas I. Barron and Kathleen Bennett. Their work appears in journals such as Cancer Epidemiology Biomarkers & Prevention, JNCI Journal of the National Cancer Institute, International Journal of Cancer, Journal of Clinical Oncology and Cancer Causes & Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.